查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018524

遠端患者監護市場中的人工智慧：按組件、技術、設備類型、交付方式、服務類型、應用和最終用戶分類——2026-2032年全球市場預測

Artificial Intelligence in Remote Patient Monitoring Market by Component, Technology, Device Type, Mode Of Delivery, Service Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，遠端患者監護人工智慧 (AI) 市場規模將達到 22.5 億美元，到 2026 年將成長至 28.7 億美元，到 2032 年將達到 116.6 億美元，複合年成長率為 26.47%。

主要市場統計數據
基準年 2025 22.5億美元
預計年份：2026年 28.7億美元
預測年份 2032 116.6億美元
複合年成長率 (%) 26.47%

展望未來，人工智慧將成為醫療保健整體方面持續護理、臨床決策支援和病人參與的基礎。

在感測技術、邊緣運算和人工智慧的推動下，遠端患者監護正從小眾的臨床輔助發展成為提供長期照護的關鍵工具。醫療系統和保險公司越來越重視減少不必要的住院治療、加強慢性病管理以及為弱勢群體提供持續監測。在此背景下，人工智慧不僅是分析能力的增強，更是將來自設備和環境感測器的連續資料流轉化為可操作的臨床洞察的基礎能力。

這清楚地表明了技術、實施和臨床檢驗方面的變化趨於一致，重新定義了我們設計、提供和監管持續遠距醫療的方式。

在遠端患者監護領域，正在發生多項變革性變化，這些變化正在重塑醫療服務的提供、評估和獲利模式。首先，感測方法日趨多樣化。非接觸式攝影機感測器和環境感測器與貼片、智慧服裝和腕帶等穿戴式裝置相輔相成，因此能夠獲得更豐富、多模態的資料集。因此，這些多樣化的輸入資料正透過先進的建模技術進行整合，例如深度學習架構、機器學習流程和自然語言處理系統，這些技術越來越能夠從臨床醫生記錄和患者互動中提取上下文資訊。

對美國關稅對全球遠端患者監護供應鏈中的設備採購、總體成本趨勢和策略選擇產生的連鎖反應進行詳細評估。

美國發起的關稅措施和貿易政策轉變可能會對遠端患者監護生態系統的供應鏈、採購成本和整體全球籌資策略產生累積的連鎖反應。對感測器、連接模組和半導體組件等硬體部件徵收關稅將增加設備的採購成本。因此，設備製造商將被迫重新考慮其採購區域，將額外成本轉嫁給買家，或接受利潤率下降的情況。由於硬體是許多遠距監護解決方案的基礎，持續的關稅措施將獎勵供應商加快本地化生產和近岸外包策略，以降低其跨境課稅風險。

一份全面的、主導細分為導向的情報簡報，重點關注組件、技術、設備、交付模式、服務、應用和最終用戶觀點，以協調產品和商業戰略。

市場細分揭示了人工智慧驅動的遠端患者監護市場的多面性，並有助於確定各組件、技術、設備類型、交付模式、服務、應用和終端用戶環境等方面的投資優先順序。從組件角度來看，該生態系統以硬體、服務和軟體為核心。硬體分為提供關鍵訊號的連接設備和監護設備。服務分為託管服務和專業服務。託管服務專注於遠距監護和支援服務，而專業服務則專注於諮詢、整合和培訓。軟體專注於分析和平台軟體，這些軟體支援數據處理和臨床醫生工作流程。

這項以區域為中心的分析說明了不同的管理體制、報銷模式和基礎設施現狀如何導致全球醫療保健市場出現不同的採用路徑。

區域趨勢對人工智慧驅動的遠端患者監護的普及軌跡、監管預期和商業化路徑產生了重大影響。在美洲，以價值醫療、居家慢性病管理以及保險公司與醫療服務提供者合作為重點的項目，正在為整合平台和管理式服務創造有利環境，這些平台和管理式服務能夠減少急診護理的使用。同時，法律規範和資料保護規範促使供應商在採購談判中優先考慮互通性和結果檢驗，將其視為商業性差異化因素。

對競爭原型、夥伴關係動態和能力領導力進行策略評估，以確定檢驗的基於人工智慧的遠端監控解決方案的主導供應商。

人工智慧驅動的遠端患者監護領域的競爭格局涉及硬體製造商、軟體平台供應商、分析專家和服務整合商，各方都在追求差異化的價值提案。硬體公司往往在感測器精度、外形規格和可製造性方面展開競爭，而平台供應商則在資料擷取、互通性和分析堆疊的深度方面脫穎而出。分析專家專注於檢驗的臨床模型、可解釋性以及多模態資料流的整合，而託管服務供應商則將監護、升級和臨床工作流程編配打包，以提供端到端的營運價值。

產業領導者正在採取一系列優先的、可操作的策略行動，以加速檢驗的部署，確保供應彈性，並使商業模式與臨床和支付方的目標保持一致。

產業領導者應共同實施一系列策略措施，以充分利用人工智慧驅動的遠端監控技術的快速發展。首先，他們應投資於模組化架構，將資料擷取和分析層與感測器分離，從而最大限度地提高互通性並減少供應商鎖定。這對企業採購委員會至關重要。其次，他們應在產品開發的早期階段優先考慮臨床檢驗和監管合規流程，以縮短部署時間並建立與支付方和醫療服務提供者的信任。第三，他們應透過建立區域製造夥伴關係和推廣關鍵零件的雙重採購來實現供應鏈多元化，從而降低關稅和物流風險。

嚴謹的混合方法研究框架，包括文獻整合、專家訪談和技術檢驗，為相關人員提供平衡、可重複和可操作的見解。

本研究途徑透過系統性地整合第二手資料與一手定性檢驗，確保了研究的穩健性、透明度和可操作性。二手資料整合活動包括對同行評審的臨床文獻、監管指導文件、醫療設備互通性標準以及揭示演算法方法和檢驗框架的技術白皮書進行結構化審查。這些資訊來源提供了技術背景，並揭示了感測方法、演算法架構和實施實踐的主流趨勢。

對技術、操作和臨床要求進行簡潔的整合，以確定誰能夠成功擴展人工智慧驅動的遠端監控程序以及原因。

人工智慧驅動的遠端患者監護正處於關鍵轉折點，技術成熟度、臨床需求和商業性目標在此交匯融合，為改善醫療服務創造了永續的機會。朝向多模態測、混合雲端和邊緣部署以及服務主導的商業化模式的轉變，正在為規模化發展開闢新的途徑，同時也提高了臨床檢驗、互通性和管治的標準。積極應對供應鏈韌性、監管合規性和證據生成的機構，將更有利於取得永續的成果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：遠端患者監護市場：按組件分類

  • 硬體
    • 連網裝置
    • 監控設備
  • 服務
    • 託管服務
      • 遠端監控
      • 支援服務
    • 專業服務
      • 諮詢
      • 一體化
      • 訓練
  • 軟體
    • 分析軟體
    • 平台軟體

第9章：遠端患者監護市場：按技術分類

  • 電腦視覺
    • 影像識別
    • 影片分析
  • 深度學習
    • 卷積類神經網路
    • 循環神經網路
  • 機器學習
    • 強化學習
    • 監督式學習
    • 無監督學習
  • 自然語言處理
    • 語音辨識
    • 文字分析

第10章：遠端患者監護市場：按設備類型分類

  • 非接觸式裝置
    • 相機型感光元件
    • 環境感測器
    • 雷達感測器
  • 穿戴式裝置
    • 修補
    • 智慧服裝
    • 腕帶

第11章 按交付方式遠端患者監護市場

  • 雲
  • 現場

第12章：遠端患者監護市場：按服務類型分類

  • 託管服務
  • 專業服務

第13章：遠端患者監護市場：按應用領域分類

  • 慢性病管理
    • 心臟監測
    • 糖尿病管理
    • 呼吸監測
  • 老年護理
    • 跌倒偵測
    • 藥物管理
  • 緊急呼叫
    • 自動提醒
    • 緊急按鈕
  • 健身監測
    • 活動追蹤
    • 營養監測

第14章遠端患者監護市場：依最終使用者分類

  • 門診部
  • 診所
  • 居家照護設施
  • 醫院

第15章：遠端患者監護市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章遠端患者監護市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：遠端患者監護市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國遠端患者監護市場

第19章：中國遠端患者監護市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuhealth Global Inc
  • AiCure, LLC
  • Apexon
  • Binah.ai Ltd
  • Biofourmis Inc.
  • Cardiomo Care, Inc.
  • ChroniSense Medical, Ltd.
  • CU-BX Automotive Technologies Ltd.
  • Current Health Limited
  • DrKumo Inc.
  • Ejenta, Inc.
  • Feebris Ltd.
  • Gyant.com, Inc.
  • Huma Therapeutics Limited
  • iBeat, Inc.
  • iHealth Labs, Inc.
  • Implicity
  • Jorie Healthcare Patners LLC
  • Myia Labs Inc.
  • Neteera Technologies Ltd.
  • Philips Healthcare
  • Resideo Technologies, Inc
  • Senseonics Holdings, Inc
  • Somatix Inc.
  • Zephyr AI
Product Code: MRR-A339DAEFAA66

The Artificial Intelligence in Remote Patient Monitoring Market was valued at USD 2.25 billion in 2025 and is projected to grow to USD 2.87 billion in 2026, with a CAGR of 26.47%, reaching USD 11.66 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.25 billion
Estimated Year [2026] USD 2.87 billion
Forecast Year [2032] USD 11.66 billion
CAGR (%) 26.47%

A forward-looking orientation on how artificial intelligence is becoming foundational to continuous care delivery, clinical decision support, and patient engagement across care settings

Remote patient monitoring is evolving from a niche clinical adjunct into an integral instrument for longitudinal care delivery, driven by advances in sensing technology, edge computing, and artificial intelligence. Healthcare systems and payers are increasingly focused on reducing avoidable hospitalizations, enhancing chronic care management, and providing continuous oversight for vulnerable populations. In this context, AI is not merely an analytic enhancement but a foundational capability that converts continuous data streams from devices and environment sensors into actionable clinical insight.

Across care pathways, the integration of analytics platforms, intelligent alerting, and adaptive clinical workflows is enabling earlier interventions and more personalized care plans. This shift is accompanied by new expectations for interoperability, data governance, and validation of algorithmic outputs. As remote monitoring expands beyond single-condition use cases, stakeholders must balance clinical efficacy, patient experience, and operational scalability to realize sustainable improvements in quality and cost of care.

A clear articulation of the converging technological, deployment, and clinical validation shifts that are redefining how continuous remote care is designed, delivered, and regulated

The landscape of remote patient monitoring is undergoing several transformative shifts that reframe how care is delivered, measured, and monetized. First, sensing modalities are diversifying: contactless camera-based and environmental sensors complement wearables such as patches, smart garments, and wristbands, enabling richer multimodal datasets. In turn, these diverse inputs are being synthesized through advanced modeling techniques including deep learning architectures, machine learning pipelines, and increasingly capable natural language processing systems that extract context from clinician notes and patient interactions.

Second, deployment models are shifting toward hybrid orchestration where cloud-hosted platforms interface with on-premise edge processing to support low-latency analytics and maintain compliance in sensitive environments. Third, service delivery is moving from one-off installations toward managed services that combine remote monitoring with support services and professional services such as consulting, integration, and training. Finally, the emphasis on clinical validation, regulatory clarity, and explainability of AI outputs is rising, prompting vendors and providers to invest more heavily in prospective studies, real-world performance monitoring, and transparent risk-management frameworks.

An in-depth appraisal of how United States tariffs can reverberate across device sourcing, total cost dynamics, and strategic choices in global remote patient monitoring supply chains

The introduction of tariffs and trade policy shifts originating from the United States can have cumulative ripple effects across supply chains, procurement costs, and global sourcing strategies for remote patient monitoring ecosystems. Tariffs targeting hardware components such as sensors, connectivity modules, and semiconductor elements increase the landed cost of devices, which in turn pressures device manufacturers to reassess sourcing geographies, pass through incremental costs to buyers, or absorb margin reductions. Because hardware forms a foundational layer of many remote monitoring solutions, sustained tariff regimes incentivize vendors to accelerate local manufacturing or nearshoring strategies that reduce exposure to cross-border levies.

Moreover, tariffs can reshape competitive dynamics by altering relative pricing between bundled offerings and software-centric services. Service providers that rely on international hardware supply may need to strengthen managed services and software monetization to maintain sustainable revenue streams. In response, cloud and on-premise platform providers are likely to emphasize modular architectures and compatibility with multiple device classes to preserve customer choice and reduce single-supplier dependency. Finally, purchasers and health systems will respond by revising procurement specifications to account for total cost of ownership, supportability, and regulatory conformity in the presence of trade-driven cost variability, encouraging longer-term contracts and strategic supplier partnerships.

A comprehensive segmentation-driven intelligence brief that clarifies component, technology, device, delivery, service, application, and end-user lenses to align product and commercial strategies

Segmentation reveals the multidimensional nature of the AI-enabled remote patient monitoring market and helps prioritize investments across components, technologies, device types, delivery modes, services, applications, and end-user settings. From a component perspective, the ecosystem is organized around hardware, services, and software; hardware splits into connectivity devices and monitoring devices that supply primary signals, services divides into managed services and professional services with managed offerings focused on remote monitoring and support services while professional services concentrate on consulting, integration, and training, and software is oriented toward analytics software and platform software that enable data processing and clinician workflows.

Technological segmentation clarifies capability stacks where computer vision, subdivided into image recognition and video analytics, and deep learning architectures such as convolutional and recurrent neural networks handle complex temporal and spatial patterns, while machine learning paradigms including reinforcement, supervised, and unsupervised learning enable adaptive models and anomaly detection; natural language processing capabilities, spanning speech recognition and text analytics, provide richer context from patient and clinician communications. Device-type segmentation distinguishes contactless devices, including camera-based sensors, environmental sensors, and radar sensors, from wearables such as patches, smart garments, and wristbands, each of which imposes different constraints on sampling frequency, battery management, and usability. Mode of delivery centers on cloud and on-premise deployments that influence latency, data residency, and integration complexity. Service-type segmentation reiterates the division between managed services and professional services, underscoring how operational support and technical enablement combine to deliver outcomes. Application segmentation maps to chronic disease management with clinical subtracks such as cardiac monitoring, diabetes management, and respiratory monitoring, to elderly care use cases like fall detection and medication management, to emergency alert functions including automated alert and panic button, and to fitness monitoring oriented around activity tracking and nutrition monitoring. Finally, end-user segmentation spans ambulatory care settings, clinics, home care settings, and hospitals, each demanding distinct regulatory postures, workflow integrations, and reimbursement considerations. Together, these segmentation lenses inform product roadmaps, partnership strategies, and evidence-generation priorities for organizations building or procuring AI-enabled remote patient monitoring solutions.

A regionally focused analysis that explains how distinct regulatory regimes, reimbursement models, and infrastructure realities drive differentiated adoption pathways across global healthcare markets

Regional dynamics materially shape adoption trajectories, regulatory expectations, and commercialization pathways for AI-enabled remote patient monitoring. In the Americas, programs focused on value-based care, home-based chronic disease management, and payer-provider collaborations create fertile ground for integrated platforms and managed services that demonstrate reductions in acute utilization. Conversely, regulatory frameworks and data protection norms encourage vendors to prioritize interoperability and outcome validation as commercial differentiators in procurement conversations.

Europe, Middle East & Africa present a heterogeneous set of drivers where strong privacy standards and country-level reimbursement pathways require adaptable deployment models; here, on-premise options and rigorous clinical evidence often determine enterprise adoption. Emerging markets within this region also offer opportunities for low-cost contactless and portable device innovations that address access and infrastructure constraints. Asia-Pacific is characterized by rapid digital health adoption, aggressive national digitization initiatives, and large patient populations that accelerate scale-up of remote monitoring programs. Buyers and vendors in this region frequently prioritize scalable cloud-native solutions and partnerships with local manufacturers to manage supply chain resilience and regulatory compliance. Across all regions, localization of clinical content, language support through natural language processing, and alignment with regional standards are essential enablers of meaningful adoption.

A strategic assessment of competitive archetypes, partnership dynamics, and capability leadership that determines which vendors are positioned to lead in validated AI-based remote monitoring solutions

The competitive landscape for AI-driven remote patient monitoring is populated by hardware manufacturers, software platform providers, analytics specialists, and service integrators that pursue differentiated value propositions. Hardware players tend to compete on sensor fidelity, form factor, and manufacturability, while platform vendors differentiate through data ingestion, interoperability, and the depth of analytics stacks. Analytics specialists emphasize validated clinical models, explainability, and integration of multi-modal data streams, whereas managed service providers package monitoring, escalation, and clinical workflow orchestration to deliver end-to-end operational value.

Strategic motions observed across the field include tighter partnerships between device manufacturers and analytics vendors to accelerate go-to-market timelines, vertical integration by organizations seeking to own the full stack from sensing to action, and a growing emphasis on evidence generation through clinical collaborations and pilots. Procurement preferences are favoring modular ecosystems that enable health systems to integrate best-of-breed components while preserving the option to scale managed services. As regulatory scrutiny of AI models increases, companies with structured compliance processes, post-deployment monitoring capabilities, and transparent validation methodologies are emerging as preferred partners for health systems and payers focused on risk-managed deployments.

A prioritized, executable set of strategic actions for industry leaders to accelerate validated deployments, ensure supply resilience, and align commercial models with clinical and payer objectives

Industry leaders should enact a coordinated set of strategic moves to capitalize on the rapid evolution of AI-enabled remote monitoring. First, invest in modular architectures that separate sensor ingestion from analytics layers to maximize interoperability and reduce vendor lock-in, which will be critical for enterprise procurement committees. Second, prioritize clinical validation and regulatory pathways early in product development to shorten time-to-deploy and to build trust with payers and providers. Third, diversify supply chains by pursuing regional manufacturing partnerships and dual-sourcing for critical components to mitigate tariff exposure and logistics risk.

Leaders must also expand managed services and training capabilities to ensure adoption at scale, embedding clinical workflows and support models that reduce cognitive burden on frontline staff. Additionally, incorporate explainability and human-in-the-loop controls within AI models to meet clinician expectations and regulatory requirements. Finally, pursue targeted partnerships that combine device innovation with analytics and service orchestration, and align commercial models with outcomes-based contracting where feasible to demonstrate value realization in real-world settings.

A rigorous mixed-methods research framework spanning literature synthesis, expert interviews, and technical validation that ensures balanced, replicable, and actionable insights for stakeholders

The research approach combines systematic secondary synthesis with primary qualitative validation to ensure robustness, transparency, and practical relevance. Secondary activities include a structured review of peer-reviewed clinical literature, regulatory guidance documents, standards for medical device interoperability, and technical white papers that illuminate algorithmic approaches and validation frameworks. These sources provide baseline technical context and identify prevailing trends in sensing modalities, algorithm architectures, and deployment practices.

Primary research incorporates interviews with clinicians, health system executives, device engineers, and regulatory experts to capture operational constraints, adoption barriers, and procurement preferences. Findings are triangulated through cross-validation between secondary evidence and primary inputs, and technical claims are assessed for reproducibility and clinical applicability. Segmentation boundaries are defined iteratively based on functional differentiation, technology stacks, and end-user workflows, while methodological limitations and assumptions are documented to support transparent interpretation of the analysis.

A concise synthesis of the technological, operational, and clinical imperatives that determine who will scale successful AI-enabled remote monitoring programs and why

AI-enabled remote patient monitoring is at a pivotal juncture where technology maturity, clinical need, and commercial appetite converge to create durable opportunities for improved care delivery. The shift toward multimodal sensing, hybrid cloud and edge deployments, and service-led commercialization models is creating new pathways to scale while raising the bar for clinical validation, interoperability, and governance. Organizations that proactively address supply chain resilience, regulatory compliance, and evidence generation will be better positioned to realize sustained impact.

Ultimately, success will depend on balancing technological innovation with pragmatic considerations of workflow integration, patient experience, and provider trust. By combining modular technical architectures, robust validation practices, and outcome-aligned commercial approaches, stakeholders can move from isolated pilots to programmatic deployments that deliver measurable improvements in patient outcomes and care efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Remote Patient Monitoring Market, by Component

  • 8.1. Hardware
    • 8.1.1. Connectivity Devices
    • 8.1.2. Monitoring Devices
  • 8.2. Services
    • 8.2.1. Managed Services
      • 8.2.1.1. Remote Monitoring
      • 8.2.1.2. Support Services
    • 8.2.2. Professional Services
      • 8.2.2.1. Consulting
      • 8.2.2.2. Integration
      • 8.2.2.3. Training
  • 8.3. Software
    • 8.3.1. Analytics Software
    • 8.3.2. Platform Software

9. Artificial Intelligence in Remote Patient Monitoring Market, by Technology

  • 9.1. Computer Vision
    • 9.1.1. Image Recognition
    • 9.1.2. Video Analytics
  • 9.2. Deep Learning
    • 9.2.1. Convolutional Neural Networks
    • 9.2.2. Recurrent Neural Networks
  • 9.3. Machine Learning
    • 9.3.1. Reinforcement Learning
    • 9.3.2. Supervised Learning
    • 9.3.3. Unsupervised Learning
  • 9.4. Natural Language Processing
    • 9.4.1. Speech Recognition
    • 9.4.2. Text Analytics

10. Artificial Intelligence in Remote Patient Monitoring Market, by Device Type

  • 10.1. Contactless Devices
    • 10.1.1. Camera Based Sensors
    • 10.1.2. Environmental Sensors
    • 10.1.3. Radar Sensors
  • 10.2. Wearable Devices
    • 10.2.1. Patches
    • 10.2.2. Smart Garments
    • 10.2.3. Wristbands

11. Artificial Intelligence in Remote Patient Monitoring Market, by Mode Of Delivery

  • 11.1. Cloud
  • 11.2. On Premise

12. Artificial Intelligence in Remote Patient Monitoring Market, by Service Type

  • 12.1. Managed Services
  • 12.2. Professional Services

13. Artificial Intelligence in Remote Patient Monitoring Market, by Application

  • 13.1. Chronic Disease Management
    • 13.1.1. Cardiac Monitoring
    • 13.1.2. Diabetes Management
    • 13.1.3. Respiratory Monitoring
  • 13.2. Elderly Care
    • 13.2.1. Fall Detection
    • 13.2.2. Medication Management
  • 13.3. Emergency Alert
    • 13.3.1. Automated Alert
    • 13.3.2. Panic Button
  • 13.4. Fitness Monitoring
    • 13.4.1. Activity Tracking
    • 13.4.2. Nutrition Monitoring

14. Artificial Intelligence in Remote Patient Monitoring Market, by End User

  • 14.1. Ambulatory Care Settings
  • 14.2. Clinics
  • 14.3. Home Care Settings
  • 14.4. Hospitals

15. Artificial Intelligence in Remote Patient Monitoring Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Artificial Intelligence in Remote Patient Monitoring Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Artificial Intelligence in Remote Patient Monitoring Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Artificial Intelligence in Remote Patient Monitoring Market

19. China Artificial Intelligence in Remote Patient Monitoring Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Accuhealth Global Inc
  • 20.6. AiCure, LLC
  • 20.7. Apexon
  • 20.8. Binah.ai Ltd
  • 20.9. Biofourmis Inc.
  • 20.10. Cardiomo Care, Inc.
  • 20.11. ChroniSense Medical, Ltd.
  • 20.12. CU-BX Automotive Technologies Ltd.
  • 20.13. Current Health Limited
  • 20.14. DrKumo Inc.
  • 20.15. Ejenta, Inc.
  • 20.16. Feebris Ltd.
  • 20.17. Gyant.com, Inc.
  • 20.18. Huma Therapeutics Limited
  • 20.19. iBeat, Inc.
  • 20.20. iHealth Labs, Inc.
  • 20.21. Implicity
  • 20.22. Jorie Healthcare Patners LLC
  • 20.23. Myia Labs Inc.
  • 20.24. Neteera Technologies Ltd.
  • 20.25. Philips Healthcare
  • 20.26. Resideo Technologies, Inc
  • 20.27. Senseonics Holdings, Inc
  • 20.28. Somatix Inc.
  • 20.29. Zephyr AI

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PLATFORM SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PLATFORM SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PLATFORM SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY IMAGE RECOGNITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY IMAGE RECOGNITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY IMAGE RECOGNITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY VIDEO ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY VIDEO ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY VIDEO ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REINFORCEMENT LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REINFORCEMENT LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY UNSUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY UNSUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SPEECH RECOGNITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SPEECH RECOGNITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TEXT ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TEXT ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TEXT ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CAMERA BASED SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CAMERA BASED SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CAMERA BASED SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RADAR SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RADAR SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RADAR SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SMART GARMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SMART GARMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SMART GARMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WRISTBANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WRISTBANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WRISTBANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RESPIRATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RESPIRATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY RESPIRATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FALL DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FALL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FALL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MEDICATION MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MEDICATION MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MEDICATION MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AUTOMATED ALERT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AUTOMATED ALERT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AUTOMATED ALERT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PANIC BUTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PANIC BUTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PANIC BUTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ACTIVITY TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ACTIVITY TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ACTIVITY TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NUTRITION MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NUTRITION MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NUTRITION MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MANAGED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY PROFESSIONAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CONTACTLESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY ELDERLY CARE, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY EMERGENCY ALERT, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY FITNESS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN REMOTE PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (U